Rationale for eliminating the hormone-free interval in modern oral contraceptives

Andrew London, Jeffrey Jensen

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Background Although most low-dose combined oral contraceptives (COCs) include 7-day hormone-free intervals (HFIs), these COCs could incompletely suppress ovarian activity. Objectives To review the impact of HFIs on ovarian suppression and tolerability, and evaluate the utility of COCs without traditional 7-day HFIs. Search strategy PubMed was searched for clinical studies published in English between January 1980 and April 2015 on the impact of HFIs and HFI modifications in COCs. Selection criteria Articles assessing contraceptive efficacy or tolerability as the primary focus were included. Data collection and analysis Abstracts of 319 articles were screened. Results Analysis of the 161 articles selected revealed that suppression of ovarian activity with low-dose COCs with 7-day HFIs is suboptimal. Loss of ovarian suppression during 7-day HFIs is commonly associated with follicular development, and most dominant follicles appear during this period. By contrast, increased ovarian suppression was noted in regimens that shortened or eliminated the HFI, or that substituted low-dose ethinyl estradiol for the HFI. Conclusions Extended regimens with modified HFIs may provide greater ovarian suppression with the potential for increased contraceptive effectiveness. Additional research is needed to evaluate whether COC regimens that include 10 μg ethinyl estradiol instead of an HFI may improve tolerability.

Original languageEnglish (US)
Pages (from-to)8-12
Number of pages5
JournalInternational Journal of Gynecology and Obstetrics
Volume134
Issue number1
DOIs
StatePublished - Jul 1 2016

Fingerprint

Oral Contraceptives
Contraceptives, Oral, Combined
Hormones
Ethinyl Estradiol
Contraceptive Agents
PubMed
Patient Selection

Keywords

  • Combined oral contraceptives
  • Extended regimen
  • Hormonal contraception
  • Hormone-free interval
  • Menstrual suppression
  • Unscheduled bleeding
  • Withdrawal bleeding

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Rationale for eliminating the hormone-free interval in modern oral contraceptives. / London, Andrew; Jensen, Jeffrey.

In: International Journal of Gynecology and Obstetrics, Vol. 134, No. 1, 01.07.2016, p. 8-12.

Research output: Contribution to journalReview article

@article{46fcf281f3ab4d24976a9ae64fcee217,
title = "Rationale for eliminating the hormone-free interval in modern oral contraceptives",
abstract = "Background Although most low-dose combined oral contraceptives (COCs) include 7-day hormone-free intervals (HFIs), these COCs could incompletely suppress ovarian activity. Objectives To review the impact of HFIs on ovarian suppression and tolerability, and evaluate the utility of COCs without traditional 7-day HFIs. Search strategy PubMed was searched for clinical studies published in English between January 1980 and April 2015 on the impact of HFIs and HFI modifications in COCs. Selection criteria Articles assessing contraceptive efficacy or tolerability as the primary focus were included. Data collection and analysis Abstracts of 319 articles were screened. Results Analysis of the 161 articles selected revealed that suppression of ovarian activity with low-dose COCs with 7-day HFIs is suboptimal. Loss of ovarian suppression during 7-day HFIs is commonly associated with follicular development, and most dominant follicles appear during this period. By contrast, increased ovarian suppression was noted in regimens that shortened or eliminated the HFI, or that substituted low-dose ethinyl estradiol for the HFI. Conclusions Extended regimens with modified HFIs may provide greater ovarian suppression with the potential for increased contraceptive effectiveness. Additional research is needed to evaluate whether COC regimens that include 10 μg ethinyl estradiol instead of an HFI may improve tolerability.",
keywords = "Combined oral contraceptives, Extended regimen, Hormonal contraception, Hormone-free interval, Menstrual suppression, Unscheduled bleeding, Withdrawal bleeding",
author = "Andrew London and Jeffrey Jensen",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.ijgo.2015.10.028",
language = "English (US)",
volume = "134",
pages = "8--12",
journal = "International Journal of Gynecology and Obstetrics",
issn = "0020-7292",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Rationale for eliminating the hormone-free interval in modern oral contraceptives

AU - London, Andrew

AU - Jensen, Jeffrey

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Background Although most low-dose combined oral contraceptives (COCs) include 7-day hormone-free intervals (HFIs), these COCs could incompletely suppress ovarian activity. Objectives To review the impact of HFIs on ovarian suppression and tolerability, and evaluate the utility of COCs without traditional 7-day HFIs. Search strategy PubMed was searched for clinical studies published in English between January 1980 and April 2015 on the impact of HFIs and HFI modifications in COCs. Selection criteria Articles assessing contraceptive efficacy or tolerability as the primary focus were included. Data collection and analysis Abstracts of 319 articles were screened. Results Analysis of the 161 articles selected revealed that suppression of ovarian activity with low-dose COCs with 7-day HFIs is suboptimal. Loss of ovarian suppression during 7-day HFIs is commonly associated with follicular development, and most dominant follicles appear during this period. By contrast, increased ovarian suppression was noted in regimens that shortened or eliminated the HFI, or that substituted low-dose ethinyl estradiol for the HFI. Conclusions Extended regimens with modified HFIs may provide greater ovarian suppression with the potential for increased contraceptive effectiveness. Additional research is needed to evaluate whether COC regimens that include 10 μg ethinyl estradiol instead of an HFI may improve tolerability.

AB - Background Although most low-dose combined oral contraceptives (COCs) include 7-day hormone-free intervals (HFIs), these COCs could incompletely suppress ovarian activity. Objectives To review the impact of HFIs on ovarian suppression and tolerability, and evaluate the utility of COCs without traditional 7-day HFIs. Search strategy PubMed was searched for clinical studies published in English between January 1980 and April 2015 on the impact of HFIs and HFI modifications in COCs. Selection criteria Articles assessing contraceptive efficacy or tolerability as the primary focus were included. Data collection and analysis Abstracts of 319 articles were screened. Results Analysis of the 161 articles selected revealed that suppression of ovarian activity with low-dose COCs with 7-day HFIs is suboptimal. Loss of ovarian suppression during 7-day HFIs is commonly associated with follicular development, and most dominant follicles appear during this period. By contrast, increased ovarian suppression was noted in regimens that shortened or eliminated the HFI, or that substituted low-dose ethinyl estradiol for the HFI. Conclusions Extended regimens with modified HFIs may provide greater ovarian suppression with the potential for increased contraceptive effectiveness. Additional research is needed to evaluate whether COC regimens that include 10 μg ethinyl estradiol instead of an HFI may improve tolerability.

KW - Combined oral contraceptives

KW - Extended regimen

KW - Hormonal contraception

KW - Hormone-free interval

KW - Menstrual suppression

KW - Unscheduled bleeding

KW - Withdrawal bleeding

UR - http://www.scopus.com/inward/record.url?scp=84975246471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975246471&partnerID=8YFLogxK

U2 - 10.1016/j.ijgo.2015.10.028

DO - 10.1016/j.ijgo.2015.10.028

M3 - Review article

C2 - 27067074

AN - SCOPUS:84975246471

VL - 134

SP - 8

EP - 12

JO - International Journal of Gynecology and Obstetrics

JF - International Journal of Gynecology and Obstetrics

SN - 0020-7292

IS - 1

ER -